Improving the Repeatability and Efficacy of Intradermal Electroporated Self-Replicating mRNA
Open Access
- 1 September 2019
- journal article
- research article
- Published by Elsevier in Molecular Therapy Nucleic Acids
- Vol. 17, 388-395
Abstract
No abstract availableKeywords
Funding Information
- Universiteit Gent (BOF15/GOA/013)
- China Scholarship Council (201607650018)
This publication has 47 references indexed in Scilit:
- Enhanced Delivery and Potency of Self-Amplifying mRNA Vaccines by Electroporation in Situ Vaccines, 2013
- Nonviral delivery of self-amplifying RNA vaccinesProceedings of the National Academy of Sciences, 2012
- Intradermal Electroporation of Naked Replicon RNA Elicits Strong Immune ResponsesPLOS ONE, 2012
- Intradermal Vaccinations With RNA Coding for TAA Generate CD8+ and CD4+ Immune Responses and Induce Clinical Benefit in Vaccinated PatientsMolecular Therapy, 2011
- Messenger RNA-based Vaccines With Dual Activity Induce Balanced TLR-7 Dependent Adaptive Immune Responses and Provide Antitumor ActivityJournal of Immunotherapy, 2011
- Lymph node mapping in the mouseJournal of Immunological Methods, 2008
- Results of the First Phase I/II Clinical Vaccination Trial With Direct Injection of mRNAJournal of Immunotherapy, 2008
- Inhibition of Human Pancreatic Ribonuclease by the Human Ribonuclease Inhibitor ProteinJournal of Molecular Biology, 2007
- Variants of ribonuclease inhibitor that resist oxidationProtein Science, 1999
- Regional variations in skin perfusion and skin thickness may contribute to varying efficacy of topical, local anaesthetics in neonatesPediatric Anesthesia, 1996